 |
Allogeneic human aortic endothelial cells cultured in a porcine gelatin matrix |
|---|---|
| Trade Name | Vascugel (R) |
| Orphan Indication | Prevention of arteriovenous fistula or arteriovenous graft failure in patients with end satge renal disease receiving hemodialysis or preparing for hemodialysis |
| USA Market Approval | USA |
| USA Designation Date | 2009-04-03 00:00:00 |
| Sponsor | Shire;300 Shire Way;Lexington, Massachusetts, 02421 |
